News
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...
Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.
The biotech is taking inspiration from cystic fibrosis treatment and applying a similar approach to developing "corrector" and "potentiator" medicines for the kidney disease.
The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...
Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European Commission (EC).
A 7-year-old girl with cystic fibrosis recently became a symbol of Libya's healthcare crisis. Her family undertook an illicit ...
This shift follows the announcement of initial positive data from the Phase 1/2 clinical trial of PM359 in Chronic ...
While most of us are familiar with type 1, type 2, and even gestational diabetes, there are actually six kinds of diabetes ...
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
WILMINGTON, N.C. (WECT) - ‘The Crossing’ is an international paddling challenge from Bimini, Bahamas to Lake Worth Beach, Florida. Organized by Piper’s Angel’s Foundation, ‘The Crossing’ helps those ...
With around 5,000 different ethno-linguistic and religious groups, India is one of the most culturally and genetically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results